Perea Rodriguez; Silvio Ernesto

Patent Applications and Registrations

Patent applications and USPTO patent grants for Perea Rodriguez; Silvio Ernesto.The latest application filed is for "pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs".

Company Profile

0.6.5

Perea Rodriguez; Silvio Ernesto - Ciudad De La Habana CU
Perea Rodriguez; Silvio Ernesto - Playa CU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs Grant 9,278,118 - Perea Rodriguez , et al. March 8, 2	2016-03-08
Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs Grant 9,226,946 - Perea Rodriguez , et al. January 5, 2	2016-01-05
Pharmaceutical Combination For The Treatment And/or Chemosensibilization Of Refractory Tumors To Anticancer Drugs App 20150111832 - Perea Rodriguez; Silvio Ernesto ; et al.	2015-04-23
Pharmaceutical Combination For The Treatment And/or Chemosensibilization Of Refractory Tumors To Anticancer Drugs App 20150030700 - Perea Rodriguez; Silvio Ernesto ; et al.	2015-01-29
Antineoplastic compounds and pharmaceutical compositions thereof Grant 8,748,411 - Rodriguez Fernandez , et al. June 10, 2	2014-06-10
Vaccine composition comprising interleukin-15 (IL-15) Grant 8,007,776 - Savio , et al. August 30, 2	2011-08-30
Antineoplastic compounds and pharmaceutical compositions thereof App 20090215730 - Rodriguez Fernandez; Rolando Eduardo ; et al.	2009-08-27
Interleukin-15 Antagonist Peptide App 20090136511 - Santos Savio; Alicia ; et al.	2009-05-28
Pharmaceutical Combination For The Treatment And Or Chemosensibilization Of Refractory Tumors To Anticancer Drugs App 20090130228 - Perea Rodriguez; Silvio Ernesto ; et al.	2009-05-21
Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors Grant 7,374,767 - Perea Rodriguez , et al. May 20, 2	2008-05-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.